Brokerages Set Cerner Co. (CERN) Target Price at $65.15

Shares of Cerner Co. (NASDAQ:CERN) have earned a consensus recommendation of “Hold” from the twenty-two analysts that are covering the company, MarketBeat.com reports. One equities research analyst has rated the stock with a sell recommendation, twelve have assigned a hold recommendation and eight have issued a buy recommendation on the company. The average 12 month price objective among brokerages that have updated their coverage on the stock in the last year is $65.15.

Several analysts recently commented on CERN shares. Royal Bank of Canada restated a “buy” rating on shares of Cerner in a research report on Wednesday, October 25th. JPMorgan Chase & Co. lowered shares of Cerner from an “overweight” rating to a “neutral” rating in a research report on Friday, October 27th. Jefferies Group restated a “buy” rating on shares of Cerner in a research report on Sunday, October 29th. SunTrust Banks reiterated a “buy” rating and issued a $75.00 target price on shares of Cerner in a research report on Monday, October 30th. Finally, Robert W. Baird upgraded shares of Cerner from a “neutral” rating to an “outperform” rating and lifted their target price for the company from $67.00 to $76.00 in a research report on Tuesday, October 31st.

In other news, VP Jeffrey A. Townsend sold 230,000 shares of the firm’s stock in a transaction dated Tuesday, February 13th. The shares were sold at an average price of $61.94, for a total value of $14,246,200.00. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, VP Michael R. Battaglioli sold 4,000 shares of the firm’s stock in a transaction dated Wednesday, December 13th. The stock was sold at an average price of $69.89, for a total transaction of $279,560.00. Following the completion of the transaction, the vice president now directly owns 4,000 shares in the company, valued at $279,560. The disclosure for this sale can be found here. Over the last three months, insiders sold 348,100 shares of company stock worth $22,519,016. Insiders own 13.11% of the company’s stock.

Large investors have recently bought and sold shares of the company. Icon Wealth Partners LLC purchased a new position in shares of Cerner in the fourth quarter worth about $107,000. Advisory Services Network LLC raised its stake in Cerner by 4.4% during the second quarter. Advisory Services Network LLC now owns 1,648 shares of the company’s stock worth $110,000 after purchasing an additional 70 shares during the period. Fuller & Thaler Asset Management Inc. purchased a new position in Cerner during the third quarter worth about $121,000. Cerebellum GP LLC purchased a new position in Cerner during the fourth quarter worth about $127,000. Finally, Steward Partners Investment Advisory LLC purchased a new position in Cerner during the third quarter worth about $128,000. 81.63% of the stock is currently owned by hedge funds and other institutional investors.

Cerner (NASDAQ:CERN) traded down $0.18 during mid-day trading on Friday, reaching $64.22. 2,522,300 shares of the company traded hands, compared to its average volume of 2,504,340. The firm has a market capitalization of $21,340.00, a price-to-earnings ratio of 30.08, a PEG ratio of 1.92 and a beta of 0.90. The company has a current ratio of 3.01, a quick ratio of 2.99 and a debt-to-equity ratio of 0.11. Cerner has a 52 week low of $54.01 and a 52 week high of $73.86.

Cerner (NASDAQ:CERN) last released its quarterly earnings results on Tuesday, February 6th. The company reported $0.58 EPS for the quarter, missing the Thomson Reuters’ consensus estimate of $0.61 by ($0.03). The firm had revenue of $1.31 billion for the quarter, compared to analyst estimates of $1.33 billion. Cerner had a net margin of 16.86% and a return on equity of 16.82%. The firm’s quarterly revenue was up 4.5% compared to the same quarter last year. During the same quarter in the prior year, the business posted $0.61 EPS. research analysts predict that Cerner will post 2.42 EPS for the current year.

TRADEMARK VIOLATION NOTICE: This news story was posted by The Ledger Gazette and is the sole property of of The Ledger Gazette. If you are viewing this news story on another site, it was copied illegally and reposted in violation of United States & international copyright & trademark legislation. The original version of this news story can be viewed at https://ledgergazette.com/2018/02/20/brokerages-set-cerner-co-cern-target-price-at-65-15.html.

About Cerner

Cerner Corporation (Cerner) is a supplier of healthcare information technology (HCIT). The Company offers a range of intelligent solutions and services that support the clinical, financial and operational needs of organizations of all sizes. The Company’s segments include Domestic and Global. The Domestic segment includes revenue contributions and expenditures associated with business activity in the United States.

Analyst Recommendations for Cerner (NASDAQ:CERN)

Receive News & Ratings for Cerner Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cerner and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply